+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer

Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer

Clinical Cancer Research 6(7): 2707-2711

Thymidylate synthase (TS) is thought to be one of the target genes that the E2F1 transcription factor binds to and regulates. However, the relationship between the expressions of TS and E2F1 in primary colon cancer specimens remains unclear. The aim of this study was to define the relation of TS and E2F1 gene expressions in tumor samples from 23 colon cancer patients. TS and E2F1 gene expressions were measured by TaqMan reverse transcription-PCR assay using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal standard and expressed as a TS:GAPDH or E2F1:GAPDH mRNA ratio. A close relationship was found between TS gene expression and E2F1 gene expression (r2 = 0.598, P < 0.001) in 23 tumor samples analyzed. Surprisingly, a high correlation between TS gene expression and E2F1 gene expression was observed even in advanced tumors from stage IV colon cancer patients. These results suggest that transcription of the TS gene may be regulated by E2F1 in primary colon cancer specimens and that this gene-regulatory pathway from E2F1 to TS may be highly conserved during malignant progression. Four of the 23 patients showed TS overexpression with increased E2F1 expression. These results suggest that the ability of a tumor to increase TS expression may possibly be due to an overexpression of E2F1. Although the number of patients was relatively small, our study provides new insights into the molecular mechanisms underlying the regulation of TS expression in colon cancers.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 047785573

Download citation: RISBibTeXText

PMID: 10914714

Related references

Elevated thymidylate synthase expression in the metastases of colon cancer correlates with increases in E2F expression. Proceedings of the American Association for Cancer Research Annual Meeting 39: 433, 1998

Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance. Clinical Cancer Research 22(5): 1243-1255, 2016

Bcl-2 expression significantly correlates with thymidylate synthase expression in colorectal cancer patients. World Journal of Gastroenterology 14(40): 6218-6223, 2008

The pemetrexed-containing treatments in the non-small cell lung cancer is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: a meta-analysis. Bmc Cancer 14: 205, 2014

Prognostic and predictive value of thymidylate synthase expression in colon cancer. Digestive Diseases and Sciences 53(5): 1289-1296, 2007

E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Clinical Cancer Research 13(23): 6938-6946, 2007

Thymidylate synthase expression in stage II and III colon cancer: a retrospective review. American Journal of Clinical Oncology 24(6): 597-602, 2002

Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer. World Journal of Gastroenterology 14(4): 617-621, 2008

RNA interference A novel mechanism for targeting thymidylate synthase expression in human colon cancer RKO cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 76, 2002

Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: prognostic potential. Clinical Cancer Research 12(7 Pt 1): 2095-2100, 2006

Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer. Oncology Reports 11(4): 839-843, 2004

A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803. Oncologist 22(1): 107-114, 2016

Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells. Anti-Cancer Drugs 15(4): 371-376, 2004

p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. Clinical Cancer Research 4(5): 1227-1234, 1998

Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer. Oncotarget 6(32): 32622-32633, 2016